"Two's a coincidence," the old adage goes; "three's a trend." So when Goldman Sachs Group Inc. recently introduced a longevity and mortality index, it seemed to be the start of a movement. Goldman joined JPMorgan Chase & Co. and Credit Suisse First Boston in a drive to create a tradeable market for a new breed of derivatives that would hedge the risks associated with lengthening lifespans. The goal, explains Alex Dubitsky, head of Goldman's longevity markets group, is to create transparent pricing for these newfangled instruments.
It's the type of product that defined benefit (DB) pension plan sponsors dream of, providing the ability to lay off what could become a plan's most volatile risk given the demographic bulge about to enter retirement age. "The potential for exposure is enormous," notes Jesse Schwartz, consulting actuary at Watson Wyatt Worldwide, which helped JPMorgan develop its LifeMetrics Index.
The Goldman product is an index swap that plan sponsors, insurers and reinsurers might use, once the market is developed, to replace other corporate efforts to spread risk. Initially, the index would more likely be used as just another investment vehicle.
Continue Reading for Free
Register and gain access to:
- Thought leadership on regulatory changes, economic trends, corporate success stories, and tactical solutions for treasurers, CFOs, risk managers, controllers, and other finance professionals
- Informative weekly newsletter featuring news, analysis, real-world case studies, and other critical content
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the employee benefits and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.